» Articles » PMID: 37586842

Increased Expression of Human Antiviral Protein MxA in FUS Proteinopathy in Amyotrophic Lateral Sclerosis

Overview
Journal Brain Pathol
Date 2023 Aug 16
PMID 37586842
Authors
Affiliations
Soon will be listed here.
Abstract

FUS mutations are one of the major mutations in familial amyotrophic lateral sclerosis (ALS). The pathological hallmark is FUS-positive neuronal cytoplasmic inclusions (FUS-NCI), known as FUS proteinopathy. Human myxovirus resistance protein 1 (MxA) is an IFN-induced dynamin-like GTPase that acts as antiviral factor. In this study, we examined the expression of MxA in neurons bearing FUS-NCI. We performed immunohistochemistry for FUS and MxA to examine the expression of MxA in two autopsy cases with different FUS gene mutations localized at the nuclear localization signal site (Case 1, H517P; Case 2, R521C). MxA. Most neurons bearing FUS-NCI have increased cytoplasmic MxA expression. Increased cytoplasmic MxA showed several distribution patterns in relation to FUS-NCIs such as the following: colocalization with NCI, distribution more widely than NCI, and different distribution peaks from NCI. Our results suggested that antiviral signaling IFNs are involved upstream in the formation of FUS-NCI in ALS-FUS patients.

Citing Articles

Increased expression of human antiviral protein MxA in FUS proteinopathy in amyotrophic lateral sclerosis.

Honda H, Yagita K, Arahata H, Hamasaki H, Noguchi H, Koyama S Brain Pathol. 2023; 34(2):e13191.

PMID: 37586842 PMC: 10901610. DOI: 10.1111/bpa.13191.

References
1.
Gao S, von der Malsburg A, Dick A, Faelber K, Schroder G, Haller O . Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. Immunity. 2011; 35(4):514-25. DOI: 10.1016/j.immuni.2011.07.012. View

2.
Baradaran-Heravi Y, Van Broeckhoven C, van der Zee J . Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol Dis. 2019; 134:104639. DOI: 10.1016/j.nbd.2019.104639. View

3.
Shelkovnikova T, An H, Skelt L, Tregoning J, Humphreys I, Buchman V . Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis. Cell Rep. 2019; 29(13):4496-4508.e4. PMC: 6941233. DOI: 10.1016/j.celrep.2019.11.094. View

4.
Kwiatkowski Jr T, Bosco D, Leclerc A, Tamrazian E, Vanderburg C, Russ C . Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009; 323(5918):1205-8. DOI: 10.1126/science.1166066. View

5.
Ruggiero E, Frasson I, Tosoni E, Scalabrin M, Perrone R, Marusic M . Fused in Liposarcoma Protein, a New Player in the Regulation of HIV-1 Transcription, Binds to Known and Newly Identified LTR G-Quadruplexes. ACS Infect Dis. 2022; 8(5):958-968. PMC: 9112328. DOI: 10.1021/acsinfecdis.1c00508. View